Val-Cit-PAB-MMAE |
| Catalog No.GC32799 |
Val-Cit-PAB-MMAE es un conjugado de fÁrmaco enlazador para ADC. Val-Cit-PAB-MMAE contiene el conector ADC (péptido Val-Cit-PAB) y un potente inhibidor de tubulina MMAE. MMAEun potente inhibidor mitÓticoal inhibir la polimerizaciÓn de tubulina.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 644981-35-1
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Val-Cit-PAB-MMAE is a drug-linker conjugate for ADC by using the anti-mitotic agent, monomethyl auristatin E (MMAE), linked via the peptide Val-Cit-PAB.
Average Rating: 5 (Based on Reviews and 9 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *